Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04421976
Other study ID # DP-Neurosurgery
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 21, 2020
Est. completion date July 1, 2021

Study information

Verified date July 2021
Source Capital Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The effect of driving pressure (DP)-guided positive end expiratory pressure (PEEP) on early postoperative pulmonary ventilation is to be determined for patients undergoing neurosurgery. Patients are recruited to receive volume controlled ventilation with either a fixed PEEP (5cmH2O) or DP titrated PEEP. Early postoperative regional distribution of lung ventilation, expressed as global inhomogeneity (GI) is evaluated by electrical impedance tomography (EIT), a noninvasive, radiation free modality. Center of ventilation (COV) by EIT, as well as the lung ultrasonography(LUS), perioperative ventilatory parameters, arterial oxygenation index (PaO2/FiO2) , serum indicators and postoperative pulmonary complications are secondary outcome variables.


Description:

After screened for preoperative risk factors, 44 patients undergoing elective neurosurgery and planned to be extubated in the operating room are randomly assigned to two groups: (1) PEEP = 5cmH2O; (2) driving pressure (DP)-guided PEEP. The ventilation protocol consists of volume-controlled mechanical ventilation (Datex Ohmeda S/5 Advance; General Electric Company Healthcare, Helsinki, Finland) at a tidal volume (VT) of 8 ml/kg predicted body weight (PBW), fresh gas of 2 litre /min, inspiratory to expiratory ratio of 1:2, and a respiratory rate adjusted to normocapnia (arterial carbon dioxide partial pressure between 35 and 45 mmHg). For group 2, trial for the lowest DP was started 10 min after position adjustment by increasing PEEP from 2 to 10 cm H2O incrementally. DP was calculated as "plateau pressure - PEEP". Each PEEP level was maintained for 10 respiratory cycles, with DP in the last cycle recorded. Then the PEEP level producing the lowest DP was identified and maintained intraoperatively. A plateau pressure of no more than 30 cmH2O is targeted in each group. Early postoperative distribution of regional ventilation global inhomogeneity (GI) is the primary endpoint evaluated by EIT (electrical impedance tomography), which was performed by a trained technician who is blinded to randomization. Center of ventilation (COV) by EIT, lung ultrasonography(LUS) , and arterial blood gas are evaluated, with inflammatory and oxidative mediators tested from venous sample. Brain relaxation will be scored by the neurosurgeon. Postoperative pulmonary complications within 3 days are also recorded.


Recruitment information / eligibility

Status Completed
Enrollment 55
Est. completion date July 1, 2021
Est. primary completion date April 1, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - Informed consent has been obtained - Elective neurosurgery - Expected ventilation duration > 2 hours - Scheduled to be extubated in the operation - American Society of Anesthesiologists (ASA) physical status >2 Exclusion Criteria: - Mechanical ventilation of > 1 hour within the last 2 weeks before surgery - Dysphagia resulting from preoperative cranial nerve damage - Body mass index = 35 kg/m2 - Acute respiratory failure (pneumonia, acute lung injury or acute respiratory distress syndrome) - Emergency surgery - Severe cardiac disease - Progressive neuromuscular illness - Pregnancy - Refusal to participate - Contradicted to EIT scan or lung ultrasound scan

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
PEEP
Driving pressure (DP) is calculated as "plateau pressure - PEEP". 10min after position adjustment, PEEP is increased from 2 to 10 cm H2O incrementally. Each PEEP level is maintained for 10 respiratory cycles, with DP in the last cycle recorded. Then the PEEP level producing the lowest DP will be identified and maintained intraoperatively.

Locations

Country Name City State
China Department of Anesthesiology,Beijing Tiantan Hospital, Capital Medical University Beijing Beijing

Sponsors (1)

Lead Sponsor Collaborator
Capital Medical University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Other Melbourne Group Scale version 2 (MGS-2) Melbourne Group Scale version 2 (MGS-2): Temperature >38°C; White cell count >11.2 or use of respiratory antibiotics; Physician diagnosis of pneumonia or chest infection; Chest X-ray findings of atelectasis/consolidation; Production of purulent (yellow/green) sputum different from preoperative sputum; Positive results upon sputum microbiological analysis; oxygen saturation by pulse oximetry (SpO2)<90% in ambient air; Re-admission to or prolonged stay (>36 h) in the intensive care unit/high dependency unit for respiratory problems. A postoperative pulmonary complication (PPC) was diagnosed if 4 or more of the 8 factors were present. within the first 3 days after surgery
Primary early postoperative overall spatial distribution of pulmonary ventilation global inhomogeneity index (GI): overall degree of spatial heterogeneity of ventilation. GI is measured by electrical impedance tomography (EIT). A smaller GI index represents a more homogeneous distribution, and a larger GI index indicates a more inhomogeneous ventilation. immediately after extubation
See also
  Status Clinical Trial Phase
Completed NCT03682198 - Neuro-Ox 2018: Assessment of Cerebral Oxygenation Under Three Clinically Relevant Conditions N/A
Withdrawn NCT00925093 - Study of Antibiotics in Cerebrospinal Fluid Following Intravenous Injection Phase 1
Completed NCT05264012 - Incidence, Risk Factors and Impact of Significant Pain in Patients Undergoing Neurosurgery
Recruiting NCT05397574 - Intraoperative Hyperspectral Imaging for Fluorescence Guided Surgery in Low Grade Gliomas
Completed NCT04153396 - Preemptive Infiltration With Betamethasone and Ropivacaine for Postoperative Pain in Laminoplasty or Laminectomy Phase 4
Recruiting NCT03087981 - Parameters Analysis in Neurosurgical Critical Patients Through Big Data Acquisition N/A
Completed NCT01513213 - Correlation of PaCO2 to the Inspired and Expired Oxygen Gradient N/A
Recruiting NCT04034836 - Parecoxib as an Adjuvant to Scalp Nerve Blocks for Relief of Post-craniotomy Pain Phase 4
Completed NCT03532256 - Post-op Crowd Sourcing Health Data Via Text-messaging
Completed NCT05108337 - Superficial Cervical Plexus Block for Postoperative Chronic Pain N/A
Completed NCT02987816 - Neurosurgical Skill Enhancement Using Transcranial Stimulation N/A
Completed NCT03193905 - Preventing Inadvertent Hypothermia in Patients Undergoing Major Spinal Surgery N/A
Completed NCT00122096 - Perioperative Inflammation and Cyclooxygenase 2 (COX-2) Phase 4
Recruiting NCT05874050 - Arterial Pressure and Surgical Hemostasis in Elective Neurosurgery.
Completed NCT01122537 - Characterization and Differential Diagnosis of Postneurosurgical Meningitis N/A
Recruiting NCT05294185 - Intra-operative Hyperspectral Imaging in Neurosurgery
Completed NCT04142203 - Implementation of 23 Hour Surgery Model in a Tertiary Hospital
Completed NCT05169281 - Distribution of Medication Disposal Packets - Acute Opioid Prescribing N/A
Recruiting NCT06264037 - The Experience in Neurorehabilitation Setting: a Qualitative Study
Recruiting NCT05860790 - Prospective Validation of Clinical Prediction Model for Venous Thromboembolism Following Neurosurgery